Role of MS Disease Modifying Therapy in Concomitant Oncologic Immune Checkpoint Inhibitor Treatment

被引：0
作者：
Siddiqui, A. [1 ]
Hersh, C. M. [1 ]
Hua, L. H. [1 ]
机构：
[1] Cleveland Clin LRCBH, Las Vegas, NV USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P424
引用
收藏
页码：214 / 215
页数：2
相关论文
共 50 条
  • [21] Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease
    Abu-Sbeih, Hamzah
    Faleck, David
    Ricciuti, Biagio
    Mendelsohn, Robin
    Naqash, Abdul Rafeh
    Cohen, Justine
    Sellers, Maclean
    Balaji, Aanika
    Ben-Betzalel, Guy
    Hajir, Ibraheim
    Zhang, Jiajia
    Awad, Mark
    Leonardi, Giulia
    Johnson, Douglas
    Pinato, David
    Owen, Dwight
    Weiss, Sarah
    Lamberti, Giuseppe
    Lythgoe, Mark
    Manuzzi, Lisa
    Arnold, Christina
    Naidoo, Jarushka
    Merkel, Gal
    Powell, Nick
    Yeung, Sai-Ching
    Sharon, Elad
    Dougan, Michael
    Wang, Yinghong
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S451 - S451
  • [22] Perspectives on Treatment of Metastatic Colorectal Cancer with Immune Checkpoint Inhibitor Therapy
    Morse, Michael A.
    Hochster, Howard
    Al Benson
    ONCOLOGIST, 2020, 25 (01) : 33 - 45
  • [23] Frequency of Relapse in Demyelinating Disease Following Immune Checkpoint Inhibitor Therapy
    Hasan, S.
    Zorio, O.
    Keegan, M.
    Weinshenker, B.
    Flanagan, E.
    Tobin, O.
    Kantarci, O.
    Toledano, M.
    Pittock, S.
    Lopez-Chiriboga, S.
    Zekeridou, A.
    Valencia-Sanchez, C.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 197 - 198
  • [24] Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease
    Abu-Sbeih, Hamzah
    Faleck, David M.
    Ricciuti, Biagio
    Mendelsohn, Robin B.
    Naqash, Abdul R.
    Cohen, Justine V.
    Sellers, Maclean C.
    Balaji, Aanika
    Ben-Betzalel, Guy
    Hajir, Ibraheim
    Zhang, Jiajia
    Awad, Mark M.
    Leonardi, Giulia C.
    Johnson, Douglas B.
    Pinato, David J.
    Owen, Dwight H.
    Weiss, Sarah A.
    Lamberti, Giuseppe
    Lythgoe, Mark P.
    Manuzzi, Lisa
    Arnold, Christina
    Qiao, Wei
    Naidoo, Jarushka
    Markel, Gal
    Powell, Nick
    Yeung, Sai-Ching J.
    Sharon, Elad
    Dougan, Michael
    Wang, Yinghong
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06) : 576 - +
  • [25] Immune thrombocytopenia after immune checkpoint inhibitor therapy
    Amanam, Idoroenyi
    Gupta, Rohan
    Pullarkat, Vinod
    Mei, Matthew
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (03) : 677 - 681
  • [26] The effect of concomitant cannabinoids during immune checkpoint inhibitor treatment of advanced stage malignancy.
    Biedny, Adam
    Szpunar, Susan
    Abdalla, Ahmed
    Kafri, Zyad
    Hadid, Tarik H.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [27] The Effect of Concomitant Usage of Analgesics on Immune Checkpoint Inhibitor-related Interstitial Lung Disease
    Manabe, T.
    Iwayama, K.
    Chuma, M.
    Tasaki, Y.
    Matsumoto, S.
    IN VIVO, 2023, 37 (03): : 1260 - 1265
  • [28] Eosinophilic reactive airways disease after immune checkpoint inhibitor treatment
    Cordial, Parker
    Bentley, Ian D.
    Horowitz, Jeffrey C.
    Ho, Kevin
    RESPIROLOGY CASE REPORTS, 2024, 12 (09):
  • [29] The role of fibrocyte in combination treatment of immune checkpoint inhibitor with antiangiogenic agents
    Mitsuhashi, Atsushi
    Ogino, Hirokazu
    Saijo, Atsuro
    Otsuka, Kenji
    Sugimoto, Masamichi
    Nokihara, Hiroshi
    Nishioka, Yasuhiko
    CANCER SCIENCE, 2022, 113 : 1267 - 1267
  • [30] Immune Checkpoint Inhibitor Combination Therapy for Renal Cell Carcinomas With Concomitant Inferior Vena Cava Thrombi
    Yoshida, Kazuhiko
    Hata, Keisuke
    Iizuka, Junpei
    Kondo, Tsunenori
    Ishihara, Hiroki
    Ishida, Hideki
    Nagashima, Yoji
    Tanabe, Kazunari
    Takagi, Toshio
    IN VIVO, 2022, 36 (02): : 1030 - 1034
12345